
Efficacy and Safety Trends with Continuous Longterm Use of Crisaborole Ointment 2% in Patients with Mild-to-Moderate Atopic Dermatitis
0:00
6:59
The poster was presented by Dr. Lebwohl and colleagues at the 2020 American Academy of Dermatology virtual annual meeting.
This audio commentary is provided by Dr. Steve Feldman.
Więcej odcinków z kanału "Research Developments in Atopic Dermatitis"



Nie przegap odcinka z kanału “Research Developments in Atopic Dermatitis”! Subskrybuj bezpłatnie w aplikacji GetPodcast.








